Introduction
Methods
Literature search strategy
1 Bone Density/ | 29 (Musc* adj2 Disabilit*).ti,ab. |
2 (Bone adj2 Densit*).ti,ab. | 30 Sarcopenia/ |
3 (Bone adj2 Mineral adj2 (Densit* or | 31 Sarcopenia.ti,ab. |
Content*)).ti,ab. | 32 exp. Muscle Strength/ |
4 Osteoporosis/ | 33 (Muscle* adj2 Strength*).ti,ab. |
5 Osteoporos*.ti,ab. | 34 (Hand adj2 Strength*).ti,ab. |
6 Osteoporosis, Postmenopausal/ | 35 (Grasp* adj2 Strength*).ti,ab. |
7 Osteoporos* Postmenopausal.ti,ab. | 36 (Grip* adj2 Strength*).ti,ab. |
8 Bone Diseases, Metabolic/ | 37 (Pinch* adj2 Strength*).ti,ab. |
9 (Bone adj2 Metabolic adj2 Disease*).ti,ab. | 38 (Physical adj2 Performance*).ti,ab. |
10 Osteopenia*.ti,ab. | 39 (Physical adj2 Endurance*).ti,ab. |
11 Bone Demineralization, Pathologic/ | 40 (Endurance* adj2 Physical adj2 Activit*).ti,ab. |
12 Bone Demineralization*.ti,ab. | 41 (Physical adj2 Abilit*).ti,ab. |
13 (Bone adj2 Loss*).ti,ab. | 42 (Physical adj2 Function*).ti,ab. |
14 (Bone adj2 Decline*).ti,ab. | 43 or/18–42 |
15 (Bone adj2 Weakness*).ti,ab. | 44 Cohort Studies/ |
16 (Bone adj2 Wasting).ti,ab. | 45 Cohort Stud*.ti,ab. |
17 or/1–16 | 46 Cohort Analys*.ti,ab. |
18 (Musc* adj2 Tissue*).ti,ab. | 47 Follow-Up Studies/ |
19 (Muscle adj2 Mass*).ti,ab. | 48 Follow Up Studi*.ti,ab. |
20 (Lean adj2 Mass*).ti,ab. | 49 Longitudinal Studies/ |
21 (Lean adj2 Body adj2 Mass*).ti,ab. | 50 Longitudinal Stud*.ti,ab. |
22 (Lean adj2 Tissue*).ti,ab. | 51 Prospective Studies/ |
23 (Fat Free adj2 Mass*).ti,ab. | 52 Prospective Stud*.ti,ab. |
24 (Fat Free adj2 Body adj2 Mass*).ti,ab. | 53 Prospective Change*.ti,ab. |
25 (Muscle* adj2 Loss*).ti,ab. | 54 or/44–53 |
26 (Muscle* adj2 Decline*).ti,ab. | 55 17 and 43 |
27 (Muscle* adj2 Weakness*).ti,ab. | 56 54 and 55 |
28 (Muscle* adj2 Wasting).ti,ab. | 57 limit 56 to (english or french) |
Study selection
Inclusion criteria | Exclusion criteria | |
---|---|---|
Design/type of study | Longitudinal follow-up (with at least two evaluations) including retrospective cohort | Animal studies Genetic studies Study protocol |
Participants | Both men and women No age restriction No restriction regarding ethnicity | Population suffering from a specific pathology Population benefiting of a treatment influencing muscle/bone status Population presenting a particular clinical condition Population benefiting from a preventive or therapeutic intervention |
Disease | Bone Mineral Density or Bone Mineral Content, regardless of the technique employed to assess it. | |
Outcome | A measure of muscle mass, muscle strength and/or physical performance, regardless of the method used to assess it or the site of the measurement of muscle mass and strength. |
Data extraction
Quality assessment
Data synthesis and statistical analysis
Results
Rendering of our literature search
Characteristics of the included studies
First author, year
| Population
“n” and type of population
Sex ratio
| Time of follow-up | Measure of bone quantity
Unit
Site(s)
Tool
| Measure of muscle components | ||
---|---|---|---|---|---|---|
Muscle Mass
Unit
Site
Tool
| Muscle strength
Unit
Site
Tool
| Physical performance
Unit
Tool
| ||||
Arabi et al., 2012 [36] | 192 older subjects (65–85 years) 66.7% of male | 4.2 years | Bone mineral density Hip, femoral neck, lumbar spine DEXA | Lean mass Subtotal body DEXA | ||
Bleicher et al., 2011 [38] | 1114 older men Not applicable | 2.1 years | Bone mineral density Hip DEXA | Lean mass Total body DEXA | ||
Chen et al., 1997 [39] | 45 postmenopausal women Not applicable | 1 year | Bone mineral density Hip, femoral neck, lumbar spine, total body DEXA | Lean mass Total body DEXA | ||
Hrafnkelsson et al., 2013 [31] | 164 school children of 7 years 57.3% of male | 2 years | Bone mineral density Hip, femoral neck, total body DEXA | Lean mass Total body DEXA | ||
Liu-Ambrose et al., 2006 [22] | 53 premenopausal women Not applicable | 12 years | Bone mineral density Hip, lumbar spine, total body DEXA | Lean mass Total body DEXA | ||
Milliken et al., 2009 [29] | 167 postmenopausal women (40–65 years) Not applicable | 4 years | Bone mineral density Hip, femoral neck DEXA | Lean mass Total body DEXA | ||
Cadogan et al., 1998 [34] | 182 elderly community-dwelling women Not applicable | 2 years | Bone mineral density Total body DEXA | Lean mass Total body DEXA | ||
Vicente-Rodriguez et al., 2005 [27] | 42 prepubertal boys Not applicable | 3.3 years | Bone mineral density Hip, femoral neck DEXA | Lean mass Total body DEXA | ||
Young et al., 2001 [25] | 286 female twins aged 8–26 years Not applicable | 1.8 years | Bone mineral density Hip, femoral neck, lumbar spine DEXA | Lean mass Total body DEXA | ||
Heidemann et al., 2015 [32] | 683 children (preschool to 4th grade) 50.9% of male | 2 years | Bone mineral content Total body DEXA | Lean mass Subtotal body DEXA | ||
Wang et al., 2007 [26] | 221 pubertal girls (10–13 years) Not applicable | 2 years | Bone mineral content Total body, left arm, left leg DEXA | Maximal Isometric Voluntary Contraction left elbow flexors, left leg extensors Dynamometer chair | ||
Sirola et al., 2006 [28] | 971 peri- and postmenopausal women Not applicable | 5.9 years | Bone mineral density Lumbar spine, femoral neck DEXA | Kilopascal Handgrip Pneumatic dynamometer | ||
Sirola et al., 2006 [11] | 587 peri- and postmenopausal women Not applicable | 10.3 years | Bone mineral density Lumbar spine, femoral neck DEXA | Kilopascal Handgrip Pneumatic dynamometer | ||
Sirola et al., 2005 [37] | 622 peri- and postmenopausal women Not applicable | 10.3 years | Bone mineral density Lumbar spine, femoral neck DEXA | Kilopascal Handgrip Pneumatic dynamometer | ||
Kwon et al., 2007 [30] | 182 elderly community-dwelling women Not applicable | 2 years | Bone mineral density Forearm DEXA | Walking speed 5-m |
Studies
| Total score (/9 points) |
---|---|
Arabi et al., 2012 [36] | 7 points |
Bleicher et al., 2011 [38] | 9 points |
Chen et al., 1997 [39] | 8 points |
Hrafnkelsson et al., 2013 [31] | 8 points |
Liu-Ambrose et al., 2006 [22] | 8 points |
Milliken et al., 2008 [29] | 8 points |
Cadogan et al. [34], | 8 points |
Vicente-Rodriguez et al., 2005 [27] | 7 points |
Young et al., 2001 [25] | 5 points |
Heidemann et al. [32], | 6 points |
Wang et al., 2007 [26] | 7 points |
Sirola et al., 2006 [11] | 7 points |
Sirola et al., 2005 [28] | 7 points |
Sirola et al., 2006 [37] | 7 points |
Kwon et al., 2007 [30] | 9 points |